Ana Lucrecia Woodward

Array ( [id] => 6616768 [patent_doc_number] => 20100003260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'PHENYLPENTADIENOYL DERIVATIVES AND THEIR USE AS PAR 1 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/305447 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6884 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003260.pdf [firstpage_image] =>[orig_patent_app_number] => 12305447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236578 [patent_doc_number] => 20100267737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => '4-PHENYLPIPERAZINE DERIVATIVES WITH FUNCTIONALIZED LINKERS AS DOPAMINE D3 RECEPTOR SELECTIVE LIGANDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/664668 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10954 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267737.pdf [firstpage_image] =>[orig_patent_app_number] => 12664668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634529 [patent_doc_number] => 08012981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Benzylpiperazine derivatives as motilin receptor agonists' [patent_app_type] => utility [patent_app_number] => 12/304539 [patent_app_country] => US [patent_app_date] => 2007-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17269 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012981.pdf [firstpage_image] =>[orig_patent_app_number] => 12304539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899867 [patent_doc_number] => 20080119481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline' [patent_app_type] => utility [patent_app_number] => 11/811379 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12395 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119481.pdf [firstpage_image] =>[orig_patent_app_number] => 11811379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199765 [patent_doc_number] => 20070299083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => '6-Methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts' [patent_app_type] => utility [patent_app_number] => 11/811150 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15460 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299083.pdf [firstpage_image] =>[orig_patent_app_number] => 11811150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670450 [patent_doc_number] => 20080045510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof' [patent_app_type] => utility [patent_app_number] => 11/811022 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14742 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045510.pdf [firstpage_image] =>[orig_patent_app_number] => 11811022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772864 [patent_doc_number] => 20080058523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Processes for synthesizing piperazine-piperidine compounds' [patent_app_type] => utility [patent_app_number] => 11/811328 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28276 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058523.pdf [firstpage_image] =>[orig_patent_app_number] => 11811328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 837030 [patent_doc_number] => 07393845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Heteroaryl derivates, their preparation and use' [patent_app_type] => utility [patent_app_number] => 11/758511 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9126 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393845.pdf [firstpage_image] =>[orig_patent_app_number] => 11758511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5011466 [patent_doc_number] => 20070281945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands' [patent_app_type] => utility [patent_app_number] => 11/809424 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9438 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281945.pdf [firstpage_image] =>[orig_patent_app_number] => 11809424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711732 [patent_doc_number] => 20080300258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'ANHYDROUS CIPROFLOXACIN HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 11/755521 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1333 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300258.pdf [firstpage_image] =>[orig_patent_app_number] => 11755521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257580 [patent_doc_number] => 20100029681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'HETEROCYCLIC COMPOUNDS AS CALCIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 12/301673 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8860 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029681.pdf [firstpage_image] =>[orig_patent_app_number] => 12301673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 583051 [patent_doc_number] => 07449468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors' [patent_app_type] => utility [patent_app_number] => 11/753848 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74008 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449468.pdf [firstpage_image] =>[orig_patent_app_number] => 11753848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555535 [patent_doc_number] => 08067436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'c-Met modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 11/753514 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83680 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067436.pdf [firstpage_image] =>[orig_patent_app_number] => 11753514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772682 [patent_doc_number] => 20080058341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'AZAINDAZOLE COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/752201 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52002 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058341.pdf [firstpage_image] =>[orig_patent_app_number] => 11752201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 795669 [patent_doc_number] => 07429585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups' [patent_app_type] => utility [patent_app_number] => 11/804955 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9757 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/429/07429585.pdf [firstpage_image] =>[orig_patent_app_number] => 11804955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555693 [patent_doc_number] => 08067594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Process for the production of benzopyran-2-ol derivatives' [patent_app_type] => utility [patent_app_number] => 12/302228 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6978 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067594.pdf [firstpage_image] =>[orig_patent_app_number] => 12302228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028953 [patent_doc_number] => 20070270400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'New compounds 303' [patent_app_type] => utility [patent_app_number] => 11/749984 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10121 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270400.pdf [firstpage_image] =>[orig_patent_app_number] => 11749984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368495 [patent_doc_number] => 20090306054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'INTEGRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/299885 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68247 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306054.pdf [firstpage_image] =>[orig_patent_app_number] => 12299885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691415 [patent_doc_number] => 20070232618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands' [patent_app_type] => utility [patent_app_number] => 11/803531 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11279 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232618.pdf [firstpage_image] =>[orig_patent_app_number] => 11803531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 338058 [patent_doc_number] => 07504399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-17 [patent_title] => 'Piperazine enamines as antiviral agents' [patent_app_type] => utility [patent_app_number] => 11/748699 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11230 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/504/07504399.pdf [firstpage_image] =>[orig_patent_app_number] => 11748699 [rel_patent_id] =>[rel_patent_doc_number] =>)